A 60-year-old with type 2 diabetes (A1C 9.1%), ASCVD and eGFR 55 has metformin 1000 mg BID. Which addition provides cardiovascular benefit independent...

Question

A 60-year-old with type 2 diabetes (A1C 9.1%), ASCVD and eGFR 55 has metformin 1000 mg BID. Which addition provides cardiovascular benefit independent of metformin?

Accepted Answer

GLP-1 receptor agonist

Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

Basal insulin

Answer

Alpha-glucosidase inhibitor

us-abfm MCQ (SBA): Type 2 Diabetes

A 60-year-old with type 2 diabetes (A1C 9.1%), ASCVD and eGFR 55 has metformin 1000 mg BID. Which addition provides cardiovascular benefit independent of metformin?